| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/27/2007 | US20070225303 8-Oxoadenine Compound |
| 09/27/2007 | US20070225302 2-Amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purines as antiviral agents |
| 09/27/2007 | US20070225266 Spiropiperidylrifamycins for the Treatment of Mycobacterial Infections |
| 09/27/2007 | US20070225260 Amino-Propanol Derivatives |
| 09/27/2007 | US20070225218 Extracellular Messengers |
| 09/27/2007 | US20070224279 Stabilization of chemical compounds using nanoparticulate formulations |
| 09/27/2007 | US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 09/27/2007 | US20070224222 Neisserial Vaccines |
| 09/27/2007 | US20070224218 Viral antigens |
| 09/27/2007 | US20070224204 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 09/27/2007 | US20070224123 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/27/2007 | US20070224122 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 09/27/2007 | DE102006012617A1 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate 4- (pyrrolopyridinyl) -pyrimidinyl-2-amine derivatives |
| 09/27/2007 | DE102006010642A1 Arzneimittelformulierungen, enthaltend Fluorchinolone Pharmaceutical formulations containing fluoroquinolones |
| 09/27/2007 | CA2647779A1 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis |
| 09/27/2007 | CA2646229A1 Deuterated hepatitis c protease inhibitors |
| 09/27/2007 | CA2646124A1 Pharmaceutically acceptable salts and polymorphic forms |
| 09/27/2007 | CA2645546A1 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases |
| 09/27/2007 | CA2641064A1 Antimicrobial protein |
| 09/27/2007 | CA2640978A1 Contraceptive composition |
| 09/27/2007 | CA2638755A1 Methods and compositions for antagonism of rage |
| 09/26/2007 | EP1837024A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 09/26/2007 | EP1836305A1 Expression vectors for treating bacterial infections |
| 09/26/2007 | EP1836225A1 Kir-binding agents and methods of use thereof |
| 09/26/2007 | EP1836211A1 Macrolides |
| 09/26/2007 | EP1836194A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 09/26/2007 | EP1836165A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases |
| 09/26/2007 | EP1836159A1 Peptidic compounds |
| 09/26/2007 | EP1835937A2 Compositions and methods for treating viral infection |
| 09/26/2007 | EP1835929A2 Anti-kir combination treatments and methods |
| 09/26/2007 | EP1835916A1 Compounds useful in the treatment of hiv |
| 09/26/2007 | EP1835900A1 Sulfasalazine analogues as nf-kb inhibitors |
| 09/26/2007 | EP1835899A1 Treatment of hcv disorders |
| 09/26/2007 | EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/26/2007 | EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/26/2007 | EP1411951B1 Enteral compositions for the prevention and/or treatment of sepsis |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
| 09/26/2007 | EP1363650B1 Composition containing pimenta extract in aquatic animal treatment methods |
| 09/26/2007 | EP1322673B1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 09/26/2007 | EP1303520B1 Therapeutic compounds and methods |
| 09/26/2007 | EP1272510B1 Pharmacologically active antiviral peptides and methods of their use |
| 09/26/2007 | EP1237571B1 Toscana virus nucleoprotein |
| 09/26/2007 | EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors |
| 09/26/2007 | EP1222255B1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 09/26/2007 | EP1035865B1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/26/2007 | EP1025212B1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 09/26/2007 | EP0787191B1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 09/26/2007 | CN101044160A Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 09/26/2007 | CN101044151A Antiviral 4'-azido-nucleosides |
| 09/26/2007 | CN101044142A 嘌呤衍生物 Purine derivatives |
| 09/26/2007 | CN101043904A Nutritional composition comprising indigestible oligosaccharides |
| 09/26/2007 | CN101043902A Vaccine composition against hepatitis c virus |
| 09/26/2007 | CN101043897A Chinese pharmaceutical compositions for treating epidemic cerebrospinal meningitis and processes for preparation thereof |
| 09/26/2007 | CN101041669A Non nucleoside reverse transcriptase inhibitors |
| 09/26/2007 | CN101041662A 3,9-dioxa four star alkyl compound and preparation method and application thereof |
| 09/26/2007 | CN101041656A Fluorine carbostyrile-oxazolidinone derivative and composition thereof, preparation method and usage |
| 09/26/2007 | CN101041641A Di-diamino dihydrogen triazine derivative and preparation method and usage thereof |
| 09/26/2007 | CN101041625A 1,1,14,14-four(2,6-dimethylphenyl)-2,13-dioxygen substitue-6,9-diammonia substitue -4,11-dihydroxy positive tetradecane compound and uses thereof |
| 09/26/2007 | CN101041076A Controlled ointment compound stroma and the preparing method |
| 09/26/2007 | CN101041066A The function of r-sHSA for treating chronic liver disease |
| 09/26/2007 | CN101041062A Anti-hepatitis B virus ascidians polypeptide medicine composition and the preparing method |
| 09/26/2007 | CN101041061A Anti-hepatitis B virus medicine agent and its preparing process |
| 09/26/2007 | CN101041051A Chinese traditional medicine compound took orally for treating Xuhan type bacterial dysentery |
| 09/26/2007 | CN101041033A Chinese medicine for treating hepatitis B |
| 09/26/2007 | CN101041029A Chinese traditional medicine for curing hepatitis B |
| 09/26/2007 | CN101041024A Medicinal composition for treating tuberculosis and its preparing process |
| 09/26/2007 | CN101041011A Chinese traditional medicine for preventing and curing AIDS |
| 09/26/2007 | CN101040995A Valid target of garlic oil and the application in preparing many kinds of medicine |
| 09/26/2007 | CN101040994A Formulation for treating beriberi |
| 09/26/2007 | CN101040983A Zizhen pills for protecting liver |
| 09/26/2007 | CN101040960A Medicine for treating hepatitis |
| 09/26/2007 | CN101040953A Injection for treating hepatitis and its preparing process |
| 09/26/2007 | CN101040952A Chinese traditional medicine injection for treating HBV and the preparing method |
| 09/26/2007 | CN101040945A Chinese traditional medicine compound took orally for creating bacterial dysentery |
| 09/26/2007 | CN101040944A Chinese traditional compound took orally for creating herpes zoster |
| 09/26/2007 | CN101040898A Diphtheritic powder |
| 09/26/2007 | CN101040890A Compound of sulfoacid flavonecosid component in chickweed and the antivirus application and the preparing method |
| 09/26/2007 | CN101040856A Compound agent including moxifloxacin and pidotimod |
| 09/26/2007 | CN101040837A Itracomazole cream and the method for preparing the same |
| 09/26/2007 | CN101040641A Thin leaf chrysanthemum tea |
| 09/26/2007 | CN101040639A Tea for digesting food and good for stomach |
| 09/26/2007 | CN100339478C Methanol yeast recombination expression liver regeneration enhancement factor and its mutant |
| 09/26/2007 | CN100339396C Multi-helix protein for inhibiting membrane virus infection, its coding gene and use |
| 09/26/2007 | CN100339395C E type hepatitis virus monoclonal antibody or its conjugated active fragment and use thereof |
| 09/26/2007 | CN100339391C Coronavirus (SARS-CoV)B-cell antigen determinate cluster with extensive cross immune activity |
| 09/26/2007 | CN100339390C Coronavirus specific T-cellantigen determinate cluster |
| 09/26/2007 | CN100339389C 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 09/26/2007 | CN100339386C Animal composite immune globulin production method |
| 09/26/2007 | CN100339384C Crystalline azithromycin, process for manufacture and pharmaceutical compositions thereof |
| 09/26/2007 | CN100339378C 6-2-(2-halogen-4-alkoxypenyl)-triazo-pyrimidine of killing fungus |
| 09/26/2007 | CN100339353C Preparation method and use of alpine yarrow herb ketoacid |
| 09/26/2007 | CN100339133C Composition of nanometer SOD and astragalus root or its extract and its preparation method |
| 09/26/2007 | CN100339130C 疫苗 Vaccine |
| 09/26/2007 | CN100339129C Use of dalbavancin compositions in preparation of medicament for treatment of bacterial infections |
| 09/26/2007 | CN100339101C Preparation and usage of |
| 09/26/2007 | CN100339084C Fosfocina calcium disperser, and its prepn. method |
| 09/26/2007 | CN100339080C Antiviral compounds |
| 09/26/2007 | CN100339077C New use of indole derivatives as anti-SARS medicine |